PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization (Q46481660)

22 December 2017

review article

1 reference

title

PPAR gamma: a novel pharmacological target against retinal and choroidal neovascularization (English)

1 reference

22 December 2017

1 reference

Bonne C

1

1 reference

22 December 2017

publication date

1 March 2005

1 reference

22 December 2017

Journal Francais d'Ophtalmologie

published in

1 reference

22 December 2017

volume

28

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

326-330

1 reference

22 December 2017

Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors

cites work

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Response of experimental retinal neovascularization to thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product?

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

The expression of the p85alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Has angiogenesis been invited to the PPARty?

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Vascular endothelial growth factors and angiogenesis in eye disease

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Therapeutic potential of thiazolidinediones as anticancer agents

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Eicosapentaenoic acid attenuates vascular endothelial growth factor-induced proliferation via inhibiting Flk-1 receptor expression in bovine carotid artery endothelial cells

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Zinc Modulates PPARγ Signaling and Activation of Porcine Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Zinc-binding of endostatin is essential for its antiangiogenic activity

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

Chromosomal Localization and Partial Genomic Structure of the Human Peroxisome Proliferator Activated Receptor-Gamma (hPPARγ) Gene

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016/S0181-5512(05)81062-9

7 January 2021

10.1016/S0181-5512(05)81062-9

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017